193 related articles for article (PubMed ID: 26429712)
1. Natural Products as Promising Therapeutics for Treatment of Influenza Disease.
Sencanski M; Radosevic D; Perovic V; Gemovic B; Stanojevic M; Veljkovic N; Glisic S
Curr Pharm Des; 2015; 21(38):5573-88. PubMed ID: 26429712
[TBL] [Abstract][Full Text] [Related]
2. Influenza neuraminidase: a druggable target for natural products.
Grienke U; Schmidtke M; von Grafenstein S; Kirchmair J; Liedl KR; Rollinger JM
Nat Prod Rep; 2012 Jan; 29(1):11-36. PubMed ID: 22025274
[TBL] [Abstract][Full Text] [Related]
3. Natural Product-Derived Phytochemicals for Influenza A Virus (H1N1) Prevention and Treatment.
Li R; Han Q; Li X; Liu X; Jiao W
Molecules; 2024 May; 29(10):. PubMed ID: 38792236
[TBL] [Abstract][Full Text] [Related]
4. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
[TBL] [Abstract][Full Text] [Related]
5. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
Renaud C; Kuypers J; Englund JA
J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
[TBL] [Abstract][Full Text] [Related]
6. The potential for multidrug-resistant influenza.
van der Vries E; Schutten M; Boucher CA
Curr Opin Infect Dis; 2011 Dec; 24(6):599-604. PubMed ID: 22001947
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology and spread of drug resistant human influenza viruses.
Hurt AC
Curr Opin Virol; 2014 Oct; 8():22-9. PubMed ID: 24866471
[TBL] [Abstract][Full Text] [Related]
8. Influenza drug resistance.
Pizzorno A; Abed Y; Boivin G
Semin Respir Crit Care Med; 2011 Aug; 32(4):409-22. PubMed ID: 21858746
[TBL] [Abstract][Full Text] [Related]
9. Issues in pharmacotherapy of 2009 H1N1 influenza infection.
Gupta YK; Padhy BM
J Postgrad Med; 2010; 56(4):321-7. PubMed ID: 20935410
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
[TBL] [Abstract][Full Text] [Related]
11. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
[TBL] [Abstract][Full Text] [Related]
12. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
[TBL] [Abstract][Full Text] [Related]
13. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.
Dharan NJ; Gubareva LV; Meyer JJ; Okomo-Adhiambo M; McClinton RC; Marshall SA; St George K; Epperson S; Brammer L; Klimov AI; Bresee JS; Fry AM;
JAMA; 2009 Mar; 301(10):1034-41. PubMed ID: 19255110
[TBL] [Abstract][Full Text] [Related]
14. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
Matsuzaki Y; Mizuta K; Aoki Y; Suto A; Abiko C; Sanjoh K; Sugawara K; Takashita E; Itagaki T; Katsushima Y; Ujike M; Obuchi M; Odagiri T; Tashiro M
Virol J; 2010 Mar; 7():53. PubMed ID: 20202225
[TBL] [Abstract][Full Text] [Related]
15. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
16. The effects of neuraminidase inhibitors on the release of oseltamivir-sensitive and oseltamivir-resistant influenza viruses from primary cultures of human tracheal epithelium.
Yamaya M; Nadine L; Kubo H; Saito K; Saito R; Nishimura H
J Med Virol; 2015 Jan; 87(1):25-34. PubMed ID: 24838828
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
[TBL] [Abstract][Full Text] [Related]
18. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
Duwe SC; Wedde M; Birkner P; Schweiger B
Antiviral Res; 2011 Jan; 89(1):115-8. PubMed ID: 21070812
[TBL] [Abstract][Full Text] [Related]
19. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
[TBL] [Abstract][Full Text] [Related]
20. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]